Heron Therapeutics INC /De
San Diego, US · Delaware corporation
Founders & leadership
ID
Ira DuarteExecutive
CC
Craig CollardExecutive
CW
Christian WaageNamed on SEC filing
CJ
Craig JohnsonNamed on SEC filing
AM
Adam MorganNamed on SEC filing
SR
Susan RodriguezNamed on SEC filing
Board
KK
Kevin KotlerBoard director
SD
Sharmila DissanaikeBoard director
Reported raises · per SEC filings
Form D private placements$30M disclosed across 1 round · 2023
▶$30MraisedAug 2023 · 7 investors · BiotechnologyRule 506(b)
▶$30MraisedAug 2023 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin KotlerDirector
- Ira DuarteExecutive Officer
- Christian WaageDirector
- Craig JohnsonDirector
- Sharmila DissanaikeDirector
- Adam MorganDirector
- Craig CollardExecutive Officer, Director
- Susan RodriguezDirector
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Heron Therapeutics INC /De raised?
- Heron Therapeutics INC /De has disclosed $30M raised across 1 round.
- Where is Heron Therapeutics INC /De headquartered?
- Heron Therapeutics INC /De is headquartered in San Diego, US.